+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07898462

Fludrocortisone Dosing Trial for Critically Ill Adults with Septic Shock Receiving Hydrocortisone Evaluating Survival and Recovery

Led by The George Institute · Updated on 2026-10-30

2200

Participants Needed

8

Research Sites

47 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the FLUDRO-SHOCK trial to find better treatments for adults with septic shock, a serious condition caused by severe infection. This phase 3 international trial compares two doses of the steroid fludrocortisone 50 mcg and 100 mcg against a placebo, alongside the usual hydrocortisone treatment. The study also investigates how a persons gene-based immune response may influence treatment effects. Up to 2,200 critically ill patients in intensive care units across multiple countries are expected to participate. Participants will receive either 50 mcg or 100 mcg of fludrocortisone acetate daily, or a matching placebo tablet, given orally or through a gastric tube for 7 days or until discharge from intensive care, whichever comes first. The study uses a randomized, double-blind design to fairly compare these treatments. Researchers will closely monitor patients during this treatment period. Throughout the study, participants survival, organ support needs, and quality of life will be tracked for up to one year after enrollment. Assessments include the number of days alive without organ support, mortality at multiple time points, new kidney therapy needs, mechanical ventilation days, hospital readmissions, new infections, and functional and health-related quality of life questionnaires. This comprehensive monitoring aims to help identify the most effective and personalized steroid treatment approach for septic shock.

CONDITIONS

Brief Title

A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone, Evaluating Survival and Functional Recovery and the Influence of Transcriptomic Response

Research Team

S

Senior Project Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here